Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andre Goy, MD
Hackensack Universeity Medical Ctr
Principal Investigator - Andrei R Shustov, MD
Seattle Cancer Care Alliance
Principal Investigator - Andres Forero-Torres, M.D.
University of Alabama at Birmingham, Comprehensive Cancer Ctr.
Principal Investigator - Elise Olsen, MD
Duke University
Principal Investigator - Francesco Turturro, MD
LSU Health Sciences Ctr., Feist-Weiller Cancer Center
Principal Investigator - Francine Foss, MD
Yale University
Principal Investigator - Gary S. Wood, MD
University of Wisconsin-Madison, Dept of Dermatology
Principal Investigator - Larisa Geskin, MD
Hillman Cancer Ctr., University of Pittsburgh
Principal Investigator - Madeleine Duvic, MD
M.D. Anderson Cancer Center - Dermatology
Principal Investigator - Miles Prince, MD
Cabrini Hospital
Principal Investigator - Nashat Gabrail, MD
Gabrail Cancer Center
Principal Investigator - Neil J Korman, MD, PhD
University Hospitals Case Medical Ctr., Dept. of Dermatology
Principal Investigator - Sareeta S Parker, MD
Emory University
Principal Investigator - Youn Kim, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cabrini Hospital
Malvern, Victoria, Australia
- Wien
Vienna, Austria
- Helsinki
Helsinki, Finland
- Hopital Hotel-Dieu
Clermont-Ferrand, France
- Creteil
Créteil, France
- Montpellier
Montpellier, France
- Pessac
Pessac, France
- Chu Robert Debre
Reims, France
- Toulouse
Toulouse, France
- Campus Charité Mitte
Berlin, Germany
- Universitatsklinikum Jena
Jena, Germany
- Universitat Kiel
Kiel, Germany
- Klinik Fur Dermatologie, Venerologie Und Allergologie
Mannheim, Germany
- Bologna
Bologna, Italy
- Firenze
Florence, Italy
- Milan
Milan, Italy
- Rome
Rome, Italy
- Torino
Torino, Italy
- Madrid
Madrid, Spain
- Zurich
Zurich, Switzerland
- London
London, United Kingdom
- Manchester
Manchester, United Kingdom
- University of Alabama at Birmingham, Comprehensive Cancer Ctr
Birmingham, Alabama, United States
- Stanford University Medical Center
Stanford, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Lsu Health Sciences Center, Feist-Weiller Cancer Center
Shreveport, Louisiana, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Hackensack University Medical Ctr
Hackensack, New Jersey, United States
- Upstate Medical University
Syracuse, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Health Sceinces, Dept. of Dermatology
Winston-Salem, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- University Hospitals Case Medical Center, Dept. of Dermatology
Cleveland, Ohio, United States
- Hospital at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Hillman Cancer Ctr., University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- M.D. Anderson Cancer Center - Dermatology
Houston, Texas, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 31 Jul 2010
- Completion
- 31 Dec 2011
- Last update posted
- 23 Jan 2012
- Registered enrollment
- 144
- Registry id
- NCT00501735
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.